(1)
Kimmel, G.; Chima, M.; Kim, H. J.; Bares, J.; Yaroshinsky, A.; Singer, G.; Kim, S. J.; Bagel, J.; Lebwohl, M. Brodalumab in the Treatment of Moderate-to-Severe Psoriasis in Patients Refractory to Anti-Interleukin-17A Therapies: Evaluation of Secondary Endpoints. J of Skin 2021, 5, 524-529.